SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by LPL Financial LLC

LPL Financial LLC lowered its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.6% in the fourth quarter, Holdings Channel reports. The firm owned 641,784 shares of the exchange traded fund’s stock after selling 52,593 shares during the quarter. LPL Financial LLC’s holdings in SPDR S&P Biotech ETF were worth $57,799,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. FMR LLC boosted its stake in shares of SPDR S&P Biotech ETF by 13.6% during the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after buying an additional 830 shares during the period. Ameritas Advisory Services LLC raised its stake in SPDR S&P Biotech ETF by 11.9% during the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock valued at $962,000 after acquiring an additional 1,137 shares during the last quarter. Van ECK Associates Corp acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $1,497,000. Hollow Brook Wealth Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 4.9% in the 3rd quarter. Hollow Brook Wealth Management LLC now owns 21,669 shares of the exchange traded fund’s stock valued at $2,141,000 after purchasing an additional 1,003 shares during the last quarter. Finally, Parallel Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF by 3.8% in the fourth quarter. Parallel Advisors LLC now owns 42,574 shares of the exchange traded fund’s stock valued at $3,834,000 after purchasing an additional 1,568 shares during the period.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $85.53 on Friday. The business has a 50 day simple moving average of $89.48 and a 200-day simple moving average of $94.06. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The stock has a market capitalization of $5.54 billion, a PE ratio of 11.47 and a beta of 0.99.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were paid a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.